Stephen Grupp

2.2k citations

19 papers · 1.6k indexed · 1 hit paper · h-index 14

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Genetics top 5%
- Mesenchymal stem cell research
- Virus-based gene therapy research

Papers in

Hematology 5
- Hematopoietic Stem Cell Transplantation 5
Neurology 6
- Neuroblastoma Research and Treatments 6

Co-authors: Margaret A. Goodell Richard C. Mulligan Hyung L. Kim Colin A. Sieff R. Paul Johnson Douglas Marks G Paradis Michael Rosenzweig
Journals: Blood (4 papers)Pediatric Blood & Cancer (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Nature Medicine (1 paper)
Partner nations: United States Canada Switzerland

In The Last Decade

Stephen Grupp

19 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species 1997 · 879 citations

Peers

Countries citing papers authored by Stephen Grupp

Since Specialization

Citations

This map shows the geographic impact of Stephen Grupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Grupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Grupp more than expected).

Fields of papers citing papers by Stephen Grupp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Grupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Grupp. The network helps show where Stephen Grupp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen Grupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Grupp Line = papers co-authored together Stephen Grupp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease Blood ·Haydar Frangoul, Franco Locatelli, Monica Bhatia, Markus Y. Mapara, Lei Yinghu, Akshay Sharma, Stephan Lobitz, Mariane de Montalembert, Damiano Rondelli, Martin H. Steinberg, Mark C. Walters, Suzan Imren, Lanju Zhang, A. Sharma, Jacobo D. Varela Traverso, C Simard, Joël Vindret, Stephen Grupp	2022	15
2	Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B‐cell acute lymphoblastic leukemia Pediatric Blood & Cancer ·D R Patel, Stephen Grupp, Amanda M. DiNofia	2021	23
3	Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma International Journal of Radiation OncologyBiologyPhysics ·Christine E. Hill‐Kayser, Zelig Tochner, Yimei Li, Goldie Kurtz, Robert A. Lustig, Paul D. James, Naomi Balamuth, Richard B. Womer, Peter Mattei, Stephen Grupp, Yaël P. Mossé, John M. Maris, Rochelle Bagatell	2019	19
4	Cardiac Profile of Chimeric Antigen Receptor T Cell Therapy in Children: A Single-Institution Experience Biology of Blood and Marrow Transplantation ·Danielle S. Burstein, Shannon L. Maude, Stephen Grupp, Heather Griffis, Masashi KOMIYAMA, Kimberly Y. Lin	2018	99
5	Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice Blood Cancer Journal ·Dashuki Mohd, David M. Barrett, Shuguang Jiang, Chongyun Fang, Michael Kalos, Stephen Grupp, Carl H. June, Yangbing Zhao	2016	46
6	Minimally Ex Vivo Manipulated Gene-Modified T Cells Display Enhanced Tumor Control Blood ·Saba Ghassemi, W Hagner, John Scholler, Selene Nuñez-Cruz, David M. Barrett, Felipe Bedoya, Joseph A. Fraietta, Simon F. Lacey, Bruce L. Levine, Stephen Grupp, Carl H. June, Michael C. Milone, J. Joseph Melenhorst	2016	3
7	Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy Blood ·Vijay Bhoj, Dimitrios C. Arhontoulis, Gerald Wertheim, L. S. Diab, Colleen Callahan, Christoph T. Ellebrecht, Amrom E. Obstfeld, Simon F. Lacey, J. Joseph Melenhorst, Farzana Nazimuddin, Wei‐Ting Hwang, Shannon L. Maude, Mariusz A. Wasik, Adam Bagg, Stephen J. Schuster, Michael D. Feldman, David L. Porter, Stephen Grupp, Carl H. June, Michael C. Milone	2016	192
8	Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? Bone Marrow Transplantation ·민진희, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, W L Carroll, Elizabeth A. Raetz, Sharon L. Gardner, Rakesh K. Goyal, Julie M. Gastier‐Foster, Michael J. Borowitz, David T. Teachey, Stephen Grupp	2015	50
9	Abstract 4707: Genetically engineered NY-ESO-1-specific T cells in HLA-A2+ patients with synovial sarcoma Cancer Research ·Melinda S. Merchant, Sandra P. D’Angelo, Hua Zhang, Donna Bernstein, トモアキイワイ, Tom Holdich, Luca Melchiori, G.I. Potra-Cicalău, Syukriah, Yoav Peretz, F. Menges, Tetsuto Minami, Bruce A. Hug, Matthew Wright, Stephen Grupp, Paul A. Meyers, William D. Tap, Bent K. Jakobsen, Crystal L. Mackall	2015	2
10	Proton versus photon radiation therapy for patients with high‐risk neuroblastoma: The need for a customized approach Pediatric Blood & Cancer ·Christine E. Hill‐Kayser, Zelig Tochner, Stefan Both, Robert A. Lustig, Anne F. Reilly, Naomi Balamuth, Richard B. Womer, John M. Maris, Stephen Grupp, Rochelle Bagatell	2013	30
11	A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study Journal of Clinical Oncology ·Susan G. Kreissman, Judith G. Villablanca, Robert C. Seeger, Stephen Grupp, Wendy B. London, John M. Maris, Gary Strickland, Susan L. Cohn, K. K. Matthay, C. Patrick Reynolds	2008	13
12	Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group Blood ·Hisaki Fujii, Geoff D.E. Cuvelier, Kevin She, 健治吉田, Hiromi Shimizu, Amina Kariminia, Mark Krailo, Zhengjia Chen, 正大金沢, Susan B. Vacek, Frederick D. Goldman, Stephen Grupp, Donna A. Wall, Andrew L. Gilman, Kirk R. Schultz	2007	104
13	Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research Leukemia ·Mary Eapen, M-J Zhang, Meenakshi Devidas, Elizabeth A. Raetz, Julio C. Barredo, A. Kim Ritchey, Kamar Godder, Stephen Grupp, Victor Lewis, Kelly M. Malloy, William L. Carroll, Stella M. Davies, Bruce M. Camitta	2007	31
14	Cell Division Rates of Primary Human Precursor B Cells in Culture Reflect In Vivo Rates Stem Cells ·Jin Chen, Robert Neely, David T. Teachey, Stephen Grupp, John Choi	2004	32
15	Primary Tumor Control in Patients With Stage 3/4 Unfavorable Neuroblastoma Treated With Tandem Double Autologous Stem Cell Transplants Journal of Pediatric Hematology/Oncology ·Karen J. Marcus, Robert C. Shamberger, Heather J. Litman, Daniel von Allmen, Stephen Grupp, О.А. Буреев, Eric Reavell, Holcombe E. Grier, Lisa Diller	2003	38
16	Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model. PubMed ·F.J. Attia, Junjie Fang, Suzanne Shusterman, Fatima Syeda Farwa, Ronald D. Barr, Bruce Pawel, Lisa Diller, Stephen Grupp	2001	5
17	Soluble Interleukin-2 Receptor Concentration As a Biochemical Indicator for Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation Journal of Hematotherapy & Stem Cell Research ·Clarissa Mathias, Rosemarie Mick, Stephen Grupp, Kathleen M. Duffy, Frank Harris, Ginna G. Laport, Edward A. Stadtmauer, Selina M. Luger, Workaferahu Ameneshewa, Mariusz A. Wasik, David Porter	2000	26
18	#504 Tandem high dose therapy for children with high-risk neuroblastoma and metastatic sarcomas Journal of Pediatric Hematology/Oncology ·F.J. Attia, Yongnan Liu, P. Luopa, Holcombe E. Grier, Jed B. Gorlin, Karen J. Marcus, Harel Weinstein, Lisa Diller, Stephen Grupp, G M Brodeur	1998	1
19	Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species Nature Medicine ·Margaret A. Goodell, Michael Rosenzweig, Hyung L. Kim, Douglas Marks, MaryAnn DeMaria, G Paradis, Stephen Grupp, Colin A. Sieff, Richard C. Mulligan, R. Paul Johnson Hit paper breakdown →	1997	879

About Stephen Grupp

Stephen Grupp is a scholar working on Hematology, Neurology, Transplantation, Cancer Research and Oncology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Neuroblastoma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Virus-based gene therapy research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Immunotherapy and Immune Responses (4 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (503 citations), Genetics (344 citations), Oncology (632 citations), Immunology (375 citations) and Molecular Biology (580 citations). Stephen Grupp has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Margaret A. Goodell, Richard C. Mulligan, Hyung L. Kim, Colin A. Sieff, R. Paul Johnson, Douglas Marks, G Paradis, Michael Rosenzweig, MaryAnn DeMaria and Shannon L. Maude. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Journal of Pediatric Hematology/Oncology, International Journal of Radiation Oncology*Biology*Physics and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact